SLC18A2 and COVID-19: Furthermore, we first investigated the expression patterns of the hypertension drug‐related genes in COVID‐19 patients by data set mining and modeling, suggesting the molecules being potentially involved in both hypertension and COVID‐19 pathology, such as JUN, LST1, and SLC18A2.